<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39407855</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>The Impact of Telemedicine during the COVID-19 Pandemic on Diabetes Management and Pregnancy Outcomes in Women with Gestational Diabetes Mellitus (GDM).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5797</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13195797</ELocationID><Abstract><AbstractText><b>Background/Objectives</b>: Gestational diabetes mellitus (GDM) can lead to various complications for both the mother and the child. Many factors influence the onset of the disease including GDM in a previous pregnancy, overweight and obesity, as well as the increasing age of women who become pregnant. The aim of this study was to assess the impact of telemedicine during the COVID-19 pandemic on diabetes management and pregnancy outcomes in women with gestational diabetes mellitus (GDM). <b>Methods:</b> A retrospective analysis was conducted. We compared two groups of GDM women from the pandemic and pre-pandemic periods in terms of pregnancy course and obstetric outcomes. <b>Results:</b> It was observed that women with GDM in the pandemic group were significantly more often overweight and significantly less often obese before pregnancy than women in the pre-pandemic group. GDM was diagnosed significantly earlier but in later pregnancies in the pandemic group than in the pre-pandemic group. The course of pregnancy in both groups was similar and the percentage of pregnancies with the delivery of neonates &gt; 4000 g did not differ significantly. The number of caesarean sections and spontaneous deliveries was also similar in both periods. No differences were found in anthropometric parameters in newborns and neonatal and maternal complications. <b>Conclusions:</b> The occurrence of the COVID-19 pandemic and the necessity of employing telemedicine tools in the medical care of women with GDM did not significantly impact diabetes management and the pregnancy outcomes achieved.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cichocka</LastName><ForeName>Edyta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0125-4323</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Diabetology and Nephrology Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gumprecht</LastName><ForeName>Janusz</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Diabetology and Nephrology Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">gestational diabetes mellitus</Keyword><Keyword MajorTopicYN="N">telemedicine</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39407855</ArticleId><ArticleId IdType="pmc">PMC11476952</ArticleId><ArticleId IdType="doi">10.3390/jcm13195797</ArticleId><ArticleId IdType="pii">jcm13195797</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Diabetes Association Professional Practice Committee 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47((Suppl. 1)):S282–S294. doi: 10.2337/dc24-S015.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc24-S015</ArticleId><ArticleId IdType="pmc">PMC10725801</ArticleId><ArticleId IdType="pubmed">38078583</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam S., McIntyre H.D., Tsoi K.Y., Kapur A., Ma R.C., Dias S., Okong P., Hod M., Poon L.C., Smith G.N., et al. Pregnancy as an opportunity to prevent type 2 diabetes mellitus: FIGO Best Practice Advice. Int. J. Gynaecol. Obstet. 2023;160((Suppl. 1)):56–67. doi: 10.1002/ijgo.14537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.14537</ArticleId><ArticleId IdType="pmc">PMC10107137</ArticleId><ArticleId IdType="pubmed">36635082</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez Y., Alpuing Radilla L.A., Delgadillo Chabolla L.E., Castillo Cruz A., Luna J., Surani S. Gestational diabetes mellitus and COVID-19: The epidemic during the pandemic. World J. Diabetes. 2023;14:1178–1193. doi: 10.4239/wjd.v14.i8.1178.</Citation><ArticleIdList><ArticleId IdType="doi">10.4239/wjd.v14.i8.1178</ArticleId><ArticleId IdType="pmc">PMC10473953</ArticleId><ArticleId IdType="pubmed">37664480</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory E.C.W., Ely D.M. Trends and Characteristics in Gestational Diabetes: United States, 2016–2020. Natl. Vital Stat. Rep. 2022;71:1–15.</Citation><ArticleIdList><ArticleId IdType="pubmed">35877134</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanardo V., Tortora D., Sandri A., Severino L., Mesirca P., Straface G. COVID-19 pandemic: Impact on gestational diabetes mellitus prevalence. Diabetes Res. Clin. Pract. 2022;183:109149. doi: 10.1016/j.diabres.2021.109149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2021.109149</ArticleId><ArticleId IdType="pmc">PMC8665826</ArticleId><ArticleId IdType="pubmed">34808282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirsky E., Mastronardi A., Paudel A.M., Young M., Zite N., Maples J. Comparison of the Prevalence of Gestational Diabetes Pre-COVID-19 Pandemic Versus During COVID-19 [A196] Obstet. Gynecol. 2022;139:57S. doi: 10.1097/01.AOG.0000826060.00417.e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.AOG.0000826060.00417.e4</ArticleId><ArticleId IdType="pmc">PMC9908741</ArticleId><ArticleId IdType="pubmed">36764456</ArticleId></ArticleIdList></Reference><Reference><Citation>La Verde M., Torella M., Riemma G., Narciso G., Iavarone I., Gliubizzi L., Palma M., Morlando M., Colacurci N., De Franciscis P. Incidence of gestational diabetes mellitus before and after the Covid-19 lockdown: A retrospective cohort study. J. Obstet. Gynaecol. Res. 2022;48:1126–1131. doi: 10.1111/jog.15205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.15205</ArticleId><ArticleId IdType="pmc">PMC9115303</ArticleId><ArticleId IdType="pubmed">35199420</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberle C., Stichling S. Telemedical Approaches to Managing Gestational Diabetes Mellitus During COVID-19: Systematic Review. JMIR Pediatr. Parent. 2021;4:e28630. doi: 10.2196/28630.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28630</ArticleId><ArticleId IdType="pmc">PMC8345174</ArticleId><ArticleId IdType="pubmed">34081604</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouhjah S., Jahanfar S. Challenges of diabetes care management in developing countries with a high incidence of COVID-19: A brief report. Diabetes Metab. Syndr. 2020;14:731–732. doi: 10.1016/j.dsx.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7235559</ArticleId><ArticleId IdType="pubmed">32473905</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre H.D., Gibbons K.S., Ma R.C.W., Tam W.H., Sacks D.A., Lowe J., Madsen L.R., Catalano P.M. Testing for gestational diabetes during the COVID-19 pandemic. An evaluation of proposed protocols for the United Kingdom, Canada and Australia. Diabetes Res. Clin. Pract. 2020;167:108353. doi: 10.1016/j.diabres.2020.108353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108353</ArticleId><ArticleId IdType="pmc">PMC7391984</ArticleId><ArticleId IdType="pubmed">32739381</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S., Meehan T., Veerasingham M., Sivanesan K. COVID-19 pandemic gestational diabetes screening guidelines: A retrospective study in Australian women. Diabetes Metab. Syndr. 2021;15:391–395. doi: 10.1016/j.dsx.2021.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.01.021</ArticleId><ArticleId IdType="pubmed">33571889</ArticleId></ArticleIdList></Reference><Reference><Citation>Munda A., Indihar B.Š., Okanovič G., Zorko K., Steblovnik L., Barlovič D.P. Maternal and Perinatal Outcomes During the COVID-19 Epidemic in Pregnancies Complicated by Gestational Diabetes. Zdr. Varst. 2023;62:22–29. doi: 10.2478/sjph-2023-0004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/sjph-2023-0004</ArticleId><ArticleId IdType="pmc">PMC9837814</ArticleId><ArticleId IdType="pubmed">36694793</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozica-Olenski S.L., Soldatos G., Marlow L., Cooray S.D., Boyle J.A. Exploring the acceptability and experience of receiving diabetes and pregnancy care via telehealth during the COVID-19 pandemic: A qualitative study. BMC Pregnancy Childbirth. 2022;22:932. doi: 10.1186/s12884-022-05175-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12884-022-05175-z</ArticleId><ArticleId IdType="pmc">PMC9745277</ArticleId><ArticleId IdType="pubmed">36514010</ArticleId></ArticleIdList></Reference><Reference><Citation>PeŐĀrez-Ferre N., Galindo M., FernaŐĀndez M.D., Velasco V., Runkle I., de la Cruz M.J., MartiŐĀn Rojas-Marcos P., Del Valle L., Calle-Pascual A.L. The outcomes of gestational diabetes mellitus after a telecare approach are not inferior to traditional outpatient clinic visits. Int. J. Endocrinol. 2010;2010:386941. doi: 10.1155/2010/386941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/386941</ArticleId><ArticleId IdType="pmc">PMC2902054</ArticleId><ArticleId IdType="pubmed">20628517</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk M., Surowiec P., Matejko B., Wróbel A., Zięba-Parkitny J., Cyganek K., Huras H., Małecki M.T. Diabetes Management Delivery and Pregnancy Outcomes in Women with Gestational Diabetes Mellitus during the First Wave of the 2020 COVID-19 Pandemic: A Single-Reference Center Report. J. Diabetes Res. 2021;2021:5515902. doi: 10.1155/2021/5515902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5515902</ArticleId><ArticleId IdType="pmc">PMC8279845</ArticleId><ArticleId IdType="pubmed">34307689</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>